Pharmaceutical Manufacturers Must Understand Cold Chain Packaging Qualification Versus Validation Requirements
Beijing, China – November 16, 2026 –

A pharmaceutical packaging supplier may say:
“This shipper has been validated for 72 hours.”
But what does “validated” actually mean?
Was one insulated box tested in a thermal chamber?
Was the final payload used?
Were summer and winter profiles evaluated?
Was the commercial shipping lane included?
Was the packout performed by actual operators?
Was the complete distribution process assessed?
These questions matter because packaging qualification and shipping-process validation are related, but they are not always the same thing.
In pharmaceutical cold chain projects, a useful distinction is:
Packaging Qualification
→ Demonstrates that a defined thermal packaging configuration can meet specified requirements under defined conditions.
Process / Shipping Validation
→ Demonstrates that the actual procedure or distribution system consistently produces the expected result under its intended conditions.
EU GDP defines qualification as demonstrating that equipment works correctly and actually leads to expected results, while validation is more broadly defined as demonstrating that a procedure, process, equipment, material, activity or system actually leads to expected results. The guidance also notes that “validation” is sometimes used broadly enough to include qualification.
This means terminology can overlap.
The important question is not simply:
“Is it validated?”
It is:
“Exactly what was qualified or validated, under which conditions, and for whose distribution process?”
1. Why the Difference Matters to Pharmaceutical Buyers
Imagine that a supplier provides a report showing:
2–8°C for 72 hours
using a specific insulated container, six PCM panels and a simulated pharmaceutical payload.
That may provide strong evidence for the tested packaging configuration.
But your actual shipment may use:
a different payload mass
another starting temperature
a different destination
another seasonal route
different operators
90 hours of real logistics exposure
The supplier’s thermal qualification is still valuable.
But it does not automatically prove that your entire commercial distribution process is validated.
FDA’s current container-closure guidance makes this distinction useful in practice: for cold-chain drug shipments, shipping containers should be appropriately qualified using temperature-recording systems, and this qualification is typically performed as part of broader shipping validation.
So:
Qualified packaging can support shipping validation, but it does not automatically replace it.
2. Start with User Requirements
Before testing begins, the project should define what the packaging is expected to do.
Typical requirements may include:
| Requirement | Example |
|---|---|
| Product Temperature | 2–8°C |
| Payload | 5 kg pharmaceutical product |
| Starting Temperature | 5°C |
| Duration | 72 hours |
| Ambient Challenge | Defined summer and winter profiles |
| Insulation | EPP, EPS, PU, VIP or selected system |
| Cooling Media | Defined PCM type and quantity |
| Monitoring | Specified sensor positions |
| Acceptance | Critical payload locations remain within range |
Without defined requirements, a test may generate data without clearly answering whether the system is suitable.
ISTA’s Passive Thermal Packaging System Operational Qualification guidance also identifies the User Requirements Specification (URS) as a best-practice element in the overall documentation package, even though the guideline itself focuses specifically on OQ.
For buyers still defining the basic packaging configuration, Glacier Spark’s Medical Temperature-Controlled Packaging Systems provide a broader framework covering temperature range, payload, insulation, PCM and packout design.
3. What Is Design Qualification?
Design Qualification, commonly referred to as DQ, addresses whether the proposed design is suitable for the defined requirements.
At this stage, the project may evaluate questions such as:
Is the container large enough for the payload?
Is the insulation structure appropriate?
Can the required amount of PCM fit without reducing payload space too much?
Can the packout be assembled repeatedly?
Are the materials suitable for the intended use?
DQ is therefore largely about confirming:
Are we designing the right system?
This stage may involve engineering calculations, prototype evaluation, component selection and preliminary thermal testing.
It should not be confused with final qualification evidence.
4. What Is Operational Qualification?
Operational Qualification, or OQ, is especially important for passive thermal packaging.
ISTA PCG-02 is specifically focused on the operational qualification of passive thermal packaging systems used for temperature-sensitive pharmaceutical and biological products. ISTA describes its purpose as establishing more standardized expectations between solution providers and life-science end users.
A thermal OQ generally evaluates a defined packaging configuration under controlled test conditions.
That can include:
defined container
defined insulation
defined PCM
defined PCM conditioning
defined payload
defined packout
defined thermal profile
defined sensor locations
defined acceptance criteria
ISTA’s guidance states that OQ testing should follow a pre-approved protocol with clear acceptance criteria, with results documented in a report.
The question being answered is roughly:
Does this defined packaging system operate as intended under the specified challenge conditions?
5. What Should an OQ Report Actually Show?
An OQ report should provide enough information for a technically competent reviewer to understand what was tested.
A useful report generally connects:
Test Objective
→
Packaging Configuration
→
Payload
→
PCM Conditioning
→
Ambient Profile
→
Sensor Placement
→
Temperature Data
→
Acceptance Criteria
→
Result
A graph showing a stable temperature line is only one part of that evidence.
For a detailed guide to evaluating these elements, see How to Read a Cold Chain Test Report: Temperature Curves, Sensor Placement and Pass/Fail Criteria.
6. OQ Does Not Mean Every Possible Packout Is Qualified
Suppose an OQ uses:
28 L insulated shipper
six 2–8°C PCM panels
5 kg simulated payload
defined summer and winter profiles
72-hour duration
That evidence belongs to that defined configuration.
If the commercial project later changes to:
four PCM panels
2 kg payload
different separators
different PCM conditioning
the original OQ should not automatically be applied without assessment.
This is one reason configuration control matters.
A thermal packaging system is not simply:
“the box.”
It is:
Container + PCM + Payload + Conditioning + Packout + Monitoring + Test Conditions
For the broader design principle, see From Box to Packout: Why Cold Chain Performance Depends on the Complete System.
7. What Is Performance Qualification?
After controlled operational qualification, the next question is:
How does the defined system perform under actual or representative distribution conditions?
This is where Performance Qualification (PQ) becomes important.
ISTA PCG-03 specifically addresses Performance Qualification and Performance Verification for thermal shipping systems and positions these activities after thermal OQ.
PQ may involve factors such as:
commercial shipping lanes
actual distribution handling
real operators
representative payloads
real transport duration
seasonal conditions
shipment temperature monitoring
The objective moves from:
Can the packaging work under controlled qualification conditions?
toward:
Does the complete shipping system perform as intended in actual use?
8. What Is Performance Verification?
Performance Verification, or PV, is closely related to PQ but is typically associated with continued evidence that the established system remains effective during ongoing use.
ISTA PCG-03 covers both PQ and PV as part of the progression following thermal OQ.
This is important because qualification should not necessarily be treated as a one-time event that can never be reconsidered.
Real distribution may change.
Examples include:
new route
new carrier
different seasonal profile
new payload
new packout operator
modified packaging component
supplier material change
These changes may need assessment to determine whether existing qualification remains applicable or whether additional verification is appropriate.
9. Qualification and Validation Are Not Simply Laboratory vs Real World
It is tempting to simplify the difference as:
Qualification = laboratory
Validation = real shipping
But that is too simplistic.
EU GDP uses the terms more broadly.
It states that wholesale distributors should identify which key equipment qualification and process validation activities are necessary, and that their scope should be determined through documented risk assessment. It also requires qualification or validation before use and after significant changes where appropriate.
So the important distinction is more about what is being demonstrated.
Qualification often focuses on whether defined equipment or a system performs correctly.
Validation often focuses more broadly on whether a process or activity consistently produces the intended result.
The exact terminology used by individual pharmaceutical companies may vary.
10. A Supplier Can Qualify Packaging Without Validating the Customer’s Supply Chain
This is one of the most important points for buyers.
A thermal packaging supplier can reasonably provide:
product specifications
packout drawings
PCM conditioning instructions
thermal OQ data
sensor maps
summer / winter test results
component documentation
But the supplier normally does not control the customer’s complete distribution process.
The customer may control:
product preparation
warehouse procedures
packout operators
carrier selection
shipping route
customs exposure
receiving procedures
temperature-excursion management
Those factors can form part of the broader distribution validation.
Therefore, a supplier should avoid saying:
“Your complete pharmaceutical supply chain is validated.”
when the evidence only supports the thermal packaging configuration.
11. EU GDP Also Looks Beyond the Packaging Box
EU GDP requires medicinal-product transportation to maintain the required storage conditions within manufacturer-defined limits and calls for a risk-based approach to transport planning.
Container and packaging selection should consider:
product storage and transport requirements
amount of product
anticipated external temperature extremes
maximum transport time including customs storage
qualification status of the packaging
validation status of shipping containers
EU GDP also requires particular attention when transportation includes unloading, reloading or temporary storage at transport hubs.
This reinforces an important principle:
A qualified box is one part of a controlled pharmaceutical distribution system.
12. Temperature Logger Placement Should Be Qualified Too
If the acceptance decision depends on temperature data, sensor placement cannot be arbitrary.
A center logger may show a stable result while:
a location near PCM becomes too cold
or
an upper payload position becomes too warm.
Development testing can therefore use multiple sensors to identify the thermal behavior of the system.
Once critical positions are understood, qualification can define repeatable monitoring locations.
For detailed guidance, see
13. Summer and Winter OQ Can Answer Different Questions
A 2–8°C packaging system may face opposite seasonal risks.
Summer OQ
The main question may be:
Can the packaging prevent the payload from exceeding 8°C?
Winter OQ
The main question may become:
Can the system prevent products from falling below 2°C?
The same logic applies to controlled room temperature packaging.
A 15–25°C system may need to protect against:
35°C summer heat
and
0°C winter cold
This is why qualification often considers multiple ambient challenges rather than one comfortable laboratory condition.
For CRT applications, see 15–25°C Pharmaceutical Shipping: How CRT Packaging Differs from 2–8°C Cold Chain.
14. Payload Matters During Qualification
A thermal qualification should not ignore payload.
The payload influences:
thermal mass
free air space
internal airflow
coolant contact
warm and cold spots
starting thermal load
An empty-box test can be useful during development.
But a qualification intended to represent a defined commercial shipment should increasingly reflect representative or justified worst-case payload conditions.
For more on this issue, see Empty-Chamber vs Loaded Thermal Testing: Why Payload Changes Cold Chain Performance.
15. The Longest Test Is Not Automatically the Best Qualification
A buyer may assume:
“If it passed 120 hours, then our 48-hour route must be validated.”
That conclusion can be unsafe if the test conditions are fundamentally different.
A 120-hour test at moderate ambient conditions may not represent a 48-hour shipment experiencing extreme summer heat.
Similarly, a 120-hour configuration may use:
more PCM
different payload
different insulation
different conditioning
Qualification relevance depends on similarity between the tested system and the intended use.
Duration is only one design input.
16. A Practical Qualification-to-Validation Path
A pharmaceutical thermal packaging project can be understood as a progression.
Stage 1 — User Requirements
Define temperature range, payload, duration, route and acceptance criteria.
Stage 2 — Design Development
Select insulation, PCM, container and packout direction.
Stage 3 — Development Testing
Compare candidate configurations and identify thermal risks.
Stage 4 — Operational Qualification
Test the defined configuration against controlled and approved criteria.
Stage 5 — Performance Qualification
Evaluate the system under representative or actual distribution conditions.
Stage 6 — Performance Verification / Ongoing Monitoring
Confirm that the established system continues to perform as expected.
Stage 7 — Change Control
Assess whether changes to payload, route, materials or procedures affect the existing qualification or validation basis.
This is a more useful framework than asking only:
“Do you have a validation report?”

17. What Documents Should Buyers Ask a Packaging Supplier For?
The exact documentation depends on the project, but a buyer may need some combination of:
| Document / Information | Purpose |
|---|---|
| Product Specification | Defines container and components |
| Packout Drawing | Defines component positions |
| PCM Specification | Identifies thermal storage material |
| Conditioning Instruction | Defines PCM starting condition |
| Payload Definition | Documents tested load |
| Thermal Test Protocol | Defines test before execution |
| OQ Report | Documents test results |
| Sensor Placement Diagram | Links temperature channels to locations |
| Temperature Data | Provides individual channel results |
| Packaging Photos | Makes packout reproducible |
| Material Information | Supports technical review |
| Change-Control Information | Helps assess future modifications |
Not every supplier needs to issue the customer’s entire validation package.
But strong supplier documentation makes the customer’s qualification and validation work much easier.
Glacier Spark’s Pharmaceutical & Medical Cold Chain Packaging Solutions combine container selection, PCM, payload protection and project-level packout support for different pharmaceutical transportation requirements.
18. What Changes May Trigger Requalification or Reassessment?
Qualification evidence is tied to a defined system.
Significant changes may therefore require technical assessment.
Examples can include:
| Change | Possible Impact |
|---|---|
| New Payload Weight | Changes thermal mass |
| New Payload Size | Changes airflow and geometry |
| Different PCM | Changes thermal capacity |
| Different PCM Quantity | Changes system energy |
| New Conditioning Procedure | Changes initial thermal state |
| Different Insulation | Changes heat transfer |
| New Route | Changes ambient exposure |
| Longer Transit | Increases thermal load |
| New Packaging Supplier | May change materials or tolerances |
| Structural Modification | May change thermal bridges |
EU GDP also states that qualification and validation should be performed after significant changes where applicable.
This does not mean every minor change automatically requires a completely new qualification program.
It means changes should be assessed through a documented, risk-based process.
Qualification vs Validation: A Quick Comparison
| Question | Packaging Qualification | Shipping / Process Validation |
|---|---|---|
| Primary Focus | Defined thermal packaging system | Broader distribution process |
| Typical Evidence | Controlled thermal test | Process and distribution evidence |
| Container Defined? | Yes | Yes, as part of process |
| PCM / Coolant Defined? | Yes | Usually part of validated procedure |
| Payload Defined? | Yes | Commercial or representative payload |
| Ambient Challenge | Controlled / predefined | Actual or representative route |
| Operators | Controlled test personnel | Operational personnel may be involved |
| Shipping Lane | May be simulated | Often becomes more relevant |
| Supplier Role | Significant | Supportive but not exclusive |
| Customer Quality Role | Review / approval | Usually central |
| Result | Qualified configuration | Evidence for validated process |
The exact terminology and documentation structure may differ between organizations, but the distinction helps prevent overclaiming.
How Glacier Spark Supports Pharmaceutical Qualification Projects
Glacier Spark can support passive thermal packaging development before and during customer qualification activities.
Packaging Configuration
EPP, EPS, rigid insulated containers and VIP-based systems can be evaluated according to payload and thermal requirements.
Pharmaceutical PCM
PCM profiles can be selected according to 2–8°C, CRT, frozen or project-specific temperature requirements.
Packout Development
PCM quantity, location, payload spacing and internal protection can be defined into a repeatable configuration.
Test Preparation
Payload conditions, temperature profiles and sensor positions can be documented for thermal testing.
Technical Documentation
Product specifications, packout drawings and available thermal-test information can support customer review.
For PCM-specific system development, see Pharmaceutical PCM Solutions.
The objective is not to replace the pharmaceutical customer’s quality system.
It is to provide a technically defined packaging configuration and supporting evidence that can form part of the customer’s qualification and validation process.
Frequently Asked QuestionsIs a thermal test report the same as a validation report?
Not necessarily.
A thermal test may support qualification of a defined packaging configuration. Broader shipping validation may also consider route, procedures, operators, commercial payload and distribution conditions.
What is OQ in cold chain packaging?
Operational Qualification evaluates whether a defined thermal packaging system performs according to predefined requirements under controlled test conditions.
What is PQ?
Performance Qualification evaluates how the established system performs under representative or actual use conditions after OQ.
Does an ISTA-tested package mean my pharmaceutical shipment is validated?
No.
ISTA testing or qualification can provide important technical evidence, but the customer must still determine whether the tested configuration and distribution conditions are relevant to the intended commercial process.
Can a packaging supplier perform OQ?
Packaging suppliers can perform or support OQ testing and provide technical documentation, subject to the customer’s quality requirements and agreed protocol.
Does changing payload require requalification?
It may require assessment. Changes in payload mass, dimensions, starting temperature or arrangement can alter thermal performance.
Is qualification required only for 2–8°C shipping?
No.
Qualification principles can also apply to CRT, frozen, ultra-cold and other defined temperature-controlled shipping systems.
Conclusion
The phrases:
Qualified Packaging
and
Validated Shipping Process
should not automatically be treated as interchangeable.
A useful pharmaceutical cold chain pathway is:
User Requirements
→
Design
→
Development Testing
→
Operational Qualification
→
Performance Qualification
→
Performance Verification
→
Change Control
The key principle is:
Qualify the defined packaging configuration, then demonstrate that the complete shipping process works in its intended use.
A supplier thermal report can provide valuable evidence.
But the strength of that evidence depends on how closely the tested configuration matches the real product, packout, route and operating procedure.
For pharmaceutical buyers, asking:
“What exactly was qualified?”
is usually more useful than simply asking:
“Is this box validated?”
Need Support for a Pharmaceutical Thermal Packaging Qualification Project?
Send Glacier Spark:
Target Temperature + Payload Dimensions + Payload Weight + Starting Temperature + Required Duration + Route + Seasonal Conditions + Preferred Container + PCM Requirement + Qualification Objective
We can help develop a defined insulated-container and PCM packout configuration with the technical information needed for thermal testing and customer qualification review.
www.glacierspark.com
About Us
Beijing Ice Region Packaging Material Co., Ltd. is a professional manufacturer and solution provider specializing in cold-chain and thermal packaging systems for global markets. With a strong focus on insulation performance, structural reliability, and sustainable materials, Ice Region is committed to delivering dependable temperature-control solutions for food, pharmaceutical, medical, and outdoor logistics applications.
Media Contact
Company Name: Beijing Ice Region Packaging Material Co., Ltd.
Contact Person: Media Relations
Email: Send Email
Country: China
Website: https://www.glacierspark.com/


